Statement Of Income

Kringle Pharma,Inc. - Filing #7592098

Concept 2021-10-01 to
2022-06-30
2020-10-01 to
2021-06-30
Statement of income
Statement of income
Net sales
112,068,000 JPY
117,825,000 JPY
Operating revenue
Net sales
Cost of sales
Cost of sales
JPY
JPY
Operating expenses
Selling, general and administrative expenses
495,175,000 JPY
422,691,000 JPY
Operating profit (loss)
-383,107,000 JPY
-304,865,000 JPY
Ordinary profit (loss)
-305,721,000 JPY
-245,177,000 JPY
Gross profit (loss)
112,068,000 JPY
117,825,000 JPY
Gross profit
Non-operating income
Non-operating income
85,774,000 JPY
82,578,000 JPY
Other
31,000 JPY
341,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Non-operating expenses
8,387,000 JPY
22,890,000 JPY
Financial expenses
Share issuance costs
JPY
6,607,000 JPY
Profit (loss) before income taxes
-305,721,000 JPY
-245,177,000 JPY
Income taxes - current
1,117,000 JPY
1,117,000 JPY
Income taxes
1,117,000 JPY
1,117,000 JPY
Profit (loss)
-306,838,000 JPY
-246,295,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.